ASX:FIJ

Fiji Kava Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume282,363 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive FIJ News and Ratings via Email

Sign-up to receive the latest news and ratings for Fiji Kava and its competitors with MarketBeat's FREE daily newsletter.

About Fiji Kava

Fiji Kava Limited operates as a medicinal kava health and wellness company in Australia, Fiji, Hong Kong, New Zealand, and the United States. It sources, produces, markets, and sells noble kava extract capsules, instant powder mixes, and flavored shots under the Fiji Kava and Taki Mai brand names. The company offers its products through supermarkets, health professionals, health food stores, retail channels, and other health-related businesses, as well as operates fijikava.com e-commerce platform. Fiji Kava Limited was founded in 2014 and is based in West End, Australia.

Unreal Deal Alert: One of Our Favorite Beaches to Reopen With a Super Sale
September 6, 2021 | msn.com

Say Hello To Leilo, The Market’s Only Ready-To-Drink Kava Beverage
August 13, 2021 | forbes.com

Fiji Kava forms strategic partnership with Chemist Warehouse Group
July 27, 2021 | proactiveinvestors.com.au

Why fans of Fiji's rugby sevens team are clutching this rare banknote during the Olympics
July 24, 2021 | msn.com

Men detained in a crowded cell for not wearing face masks amid Fiji's worsening COVID-19 outbreak
July 23, 2021 | msn.com

Canadian company hopes to capitalize on psychedelics craze with new drink
July 9, 2021 | msn.com

Isolated in the South Pacific, Fiji struggles as infections rise.
June 18, 2021 | nytimes.com

Global Weekly Cases Drop to Lowest Since Mid-March: Virus Update
June 7, 2021 | bloomberg.com

Authorities blame kava-drinking for accelerating the COVID-19 outbreak in Fiji
June 2, 2021 | msn.com

Covid-19 Live Updates: Vaccines Protect Against Some Variants, Studies Show
May 6, 2021 | nytimes.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: ASX
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: ASX:FIJ
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: fijikava.com
Phone: 61 8 6489 1600
Employees: N/A
Year Founded: N/A

Sales & Book Value

Annual Sales: $1.17 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 3.03
Book Value: A$0.02 per share
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 9.18
Current Ratio: 4.10
Quick Ratio: 2.72

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: N/A
Market Cap: N/A
Next Earnings Date: N/A
Optionable: Not Optionable

MarketRank^™

Overall MarketRank^™

0.91 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Fiji Kava.

4.5 Community Rank

Outperform Votes
Fiji Kava has received 15 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Fiji Kava has received 7 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Fiji Kava has received 68.18% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Fiji Kava and other stocks. Vote “Outperform” if you believe FIJ will outperform the S&P 500 over the long term. Vote “Underperform” if you believe FIJ will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Fiji Kava does not currently pay a dividend.
Dividend Growth
Fiji Kava does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Fiji Kava insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Fiji Kava (ASX:FIJ) Frequently Asked Questions

What stocks does MarketBeat like better than Fiji Kava?: Wall Street analysts have given Fiji Kava a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Fiji Kava wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.
Who are Fiji Kava's key executives?: Fiji Kava's management team includes the following people:
Mr. Zane Yoshida B.Tech., M.B.A., Founder & Independent Non-Exec. Director
Mr. Franc Zvonar, Chief Marketing Officer
Mr. James Richard Stephenson CMA, P.Geo, MBA, FCPA, FGIA, MAICD, CPA, CMA and F, Company Sec. (Age 55, Pay $41.61k)
Dr. Anthony Noble, Chief Exec. Officer
Prof. Jerome Sarris, Member Scientific Advisory Board & Chief Scientist
Who are some of Fiji Kava's key competitors?: Some companies that are related to Fiji Kava include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR) and Annovis Bio (ANVS).
View all of FIJ's competitors.
What is Fiji Kava's stock symbol?: Fiji Kava trades on the ASX under the ticker symbol "FIJ."
How much money does Fiji Kava make?: Fiji Kava has a market capitalization of $0.00 and generates $1.17 million in revenue each year.
What is Fiji Kava's official website?: The official website for Fiji Kava is fijikava.com.
How can I contact Fiji Kava?: The company can be reached via phone at 61 8 6489 1600.

This page was last updated on 10/24/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.